Eli Lilly is walking through the Gate, inking a deal worth up to $856 million with a biotech aiming to build out a new small ...

Eli Lilly ( LLY 0.64%) has been one of the best-performing pharmaceutical leaders in the past five years. Thanks to strong ...

Second-quarter earnings come amid many high-level challenges for the biopharma industry. How will these five closely watched ...

In its first-ever WNBA Partnerships Report-released just after the league's 2025 All-Star Weekend-sports and entertainment ...

Device CDMO and healthcare packaging pro Sanner is expanding its global presence with the opening of a new manufacturing facility in Greensboro, North Carolina. | Device CDMO and healthcare packaging ...

Generic drugmaker Lupin has received U.S. Food and Drug Administration approval for its abbreviated new drug applications for ...

Lupin has received USFDA approval for generic diabetes medications, specifically Liraglutide Injection and Glucagon for ...

Lupin receives USFDA approval for generic diabetes medications, including Liraglutide Injection and Glucagon for Injection.

Lupin receives US FDA approvals for liraglutide and Glucagon injectable products: Our Bureau, Mumbai Thursday, July 24, 2025, 12:20 Hrs [IST] Global pharma major Lupin Limited (Lu ...